Dicaris Tablet (Levamisole)

Dicaris Tablet (Levamisole) — A Complete Guide

Dicaris Tablet is an oral prescription medicine containing levamisole as its active ingredient. It is one of the most widely recognised and long-established brand names for levamisole in the global pharmaceutical market, with a history of clinical use spanning several decades across multiple countries and medical specialties. Dicaris tablets are used primarily as an antiparasitic medicine for the treatment of intestinal worm infections, but levamisole’s well-documented immunomodulatory properties have also made Dicaris a subject of interest and clinical use in immune-related conditions, including vitiligo, recurrent aphthous stomatitis, and as a historical adjunct in certain oncology protocols.

Dicaris is manufactured in different strengths depending on the market and intended use — commonly available as 50 mg tablets for use in children and as 150 mg tablets for adult antiparasitic dosing. The tablet is taken orally and is generally well tolerated at standard therapeutic doses, making it a practical and accessible treatment option for a wide range of patients.

What sets Dicaris apart from many other antiparasitic medicines is its dual identity. It is simultaneously an antiparasitic agent that causes rapid paralysis and expulsion of intestinal worms, and an immunomodulator that can influence and restore immune function. This combination of properties gives levamisole — and by extension Dicaris — a broader therapeutic relevance than most single-purpose antiparasitic medicines.

History and Background of Dicaris:-

Levamisole, the active ingredient in Dicaris, was first synthesised in 1966 by Janssen Pharmaceutica in Belgium. It was initially developed and introduced as an antiparasitic medicine for both human and veterinary use, quickly proving effective against a range of intestinal nematode infections. Within a few years of its introduction, it became one of the most widely used antiparasitic medicines in the world.

In the 1970s, researchers discovered levamisole’s immunomodulatory properties — its ability to stimulate and regulate immune responses, particularly in patients with depressed immune function. This opened up new avenues of clinical use, and levamisole was investigated as an adjunct treatment for various cancers, autoimmune conditions, and immune deficiency states. Its most notable oncology application was in combination with fluorouracil for adjuvant treatment of colorectal cancer, for which it received FDA approval in 1990 — though this use has since been largely superseded by newer and more effective regimens.

Today, Dicaris continues to be widely used across many countries — particularly in Asia, the Middle East, and parts of Africa and Latin America — as a trusted and cost-effective antiparasitic and immunomodulatory medicine. Its long track record of safety and clinical effectiveness has kept it relevant in modern medical practice despite being a decades-old compound.

What Is Levamisole?

Levamisole is a synthetic compound belonging to the imidazothiazole chemical class. It is distinct from the benzimidazole antiparasitic medicines — such as mebendazole, albendazole, and fenbendazole — in both its chemical structure and its mechanism of action.

As an antiparasitic agent, levamisole works by causing neuromuscular paralysis in susceptible worm species — specifically spastic paralysis, where the worm’s muscles lock in a state of sustained contraction. As an immunomodulator, it works by influencing T-lymphocyte activity, enhancing macrophage function, and restoring depressed immune responses toward a more balanced and effective state.

Levamisole is rapidly absorbed after oral administration and has a relatively short half-life, which is one of the reasons the intermittent dosing schedules used for immunomodulatory purposes have proven effective — the medicine produces its biological effects without needing to be continuously present in the bloodstream.

How Does Dicaris Tablet Work?

Dicaris Tablet exerts its therapeutic effects through two distinct and well-characterised mechanisms, each relevant to a different clinical application.

Antiparasitic mechanism — spastic paralysis: Levamisole acts as a selective agonist at nicotinic acetylcholine receptors in the muscles and nervous system of parasitic nematode worms. By binding to and continuously activating these receptors, it mimics the effect of acetylcholine — the natural nerve-muscle signalling chemical — causing the worm’s muscles to contract continuously and forcefully without relaxing. This sustained contraction produces spastic paralysis — the worm stiffens, loses its grip on the intestinal wall, and is expelled from the body through normal bowel movements. This process occurs relatively quickly, often within hours of the dose being absorbed, making levamisole one of the faster-acting antiparasitic options available.

The selectivity of levamisole for nematode nicotinic receptors over human nicotinic receptors is what makes it safe at therapeutic doses — the paralytic effect is directed at the parasites rather than the human host.

Immunomodulatory mechanism — immune restoration: At the cellular level, levamisole influences several components of the immune system in ways that tend to restore normal function rather than broadly suppress or stimulate it. Key immunomodulatory effects include stimulation of T-lymphocyte proliferation and function — particularly regulatory T-cells that prevent autoimmune responses, enhancement of macrophage activity and phagocytosis, restoration of neutrophil chemotaxis and function in patients with depressed immune activity, and normalisation of cytokine balance in patients with immune dysregulation. These properties make levamisole particularly relevant in conditions where the immune system is either underactive — as in some parasitic infections — or dysregulated — as in autoimmune conditions like vitiligo and recurrent aphthous stomatitis.

What Is Dicaris Used For?

Dicaris has several established and emerging clinical applications based on its dual antiparasitic and immunomodulatory properties.

Primary antiparasitic use: Dicaris is most widely prescribed for the treatment of intestinal nematode infections — particularly ascariasis caused by the roundworm Ascaris lumbricoides. It is effective against a range of parasitic species and is used in both individual patient treatment and mass deworming programmes. It is highly regarded for its single-dose efficacy against roundworms, which makes it a practical and cost-effective deworming option.

Vitiligo: Dicaris Tablet is used as a systemic immunomodulatory treatment for vitiligo, particularly in patients with active or progressive non-segmental vitiligo. By helping to restore regulatory T-cell function and reduce the autoimmune attack on melanocytes, levamisole can slow disease progression and support repigmentation — especially when used in combination with phototherapy or topical treatments.

Recurrent aphthous stomatitis: Recurrent aphthous stomatitis — commonly known as recurrent mouth ulcers — has an immune-mediated component, and levamisole has been studied and used clinically to reduce the frequency and severity of ulcer episodes. The intermittent dosing protocol used for this indication is similar to that used for vitiligo.

Nephrotic syndrome in children: In paediatric medicine, levamisole has been used as a steroid-sparing agent in children with frequently relapsing nephrotic syndrome — a kidney condition involving significant protein loss in the urine. By modulating the immune response that drives the condition, levamisole can help maintain remission while reducing the need for long-term corticosteroids.

Historical oncology use: Dicaris was historically used as part of adjuvant chemotherapy for colorectal cancer in combination with fluorouracil. While this application is now largely historical in high-resource settings, it remains relevant in some regions and continues to be studied in various cancer research contexts.

Worm Infections Treated by Dicaris Tablet:-

As an antiparasitic medicine, Dicaris Tablet is effective against several common intestinal nematode species:

• Roundworm (Ascaris lumbricoides) — the primary and most common indication. Dicaris is considered one of the most effective single-dose treatments for ascariasis
• Hookworms (Ancylostoma duodenale and Necator americanus) — blood-feeding worms causing anaemia and protein deficiency with heavy infections
• Pinworms or Threadworms (Enterobius vermicularis) — common in children, causing anal itching, particularly at night
• Strongyloides stercoralis — a threadworm capable of autoinfection and long-term persistence without treatment
• Trichostrongylus species — intestinal worms acquired through contaminated soil or animal contact

Dosage and How to Take Dicaris Tablet?

Dosage instructions should always be confirmed with a doctor or pharmacist. The following is general guidance only.

For intestinal worm infections — adults: The standard adult antiparasitic dose is 150 mg taken as a single dose. This is typically achieved with one 150 mg tablet or three 50 mg tablets taken together. A single dose is often curative for roundworm infections. For other worm species or mixed infections, a doctor may recommend a repeat dose or a different treatment schedule.

For intestinal worm infections — children: Dosing is weight-based at approximately 2.5 mg per kilogram of body weight as a single dose. For example, a child weighing 20 kg would receive approximately 50 mg as a single dose. Always have a paediatrician or doctor determine the exact dose for a child.

For vitiligo and other immunomodulatory indications: The typical schedule for vitiligo is an intermittent protocol — usually 50 mg twice daily on two consecutive days per week. This provides a total of 200 mg per week while minimising cumulative side effects. The schedule should be prescribed and monitored by a dermatologist.

For recurrent aphthous stomatitis: A similar intermittent protocol to that used for vitiligo is commonly used — typically 150 mg once weekly or 50 mg twice daily on two days per week. Your doctor will determine the most appropriate schedule.

General instructions:

• Take Dicaris Tablet with food or immediately after a meal to reduce stomach discomfort
• Swallow the tablet whole with a full glass of water
• The tablet may be crushed and mixed with food for patients who have difficulty swallowing
• Follow the prescribed schedule consistently — do not skip doses or adjust the schedule without consulting your doctor
• Avoid alcohol on dosing days and for at least 24 hours afterward

Who Should Take Dicaris Tablet?

Dicaris Tablet may be prescribed for:

• Adults and children with confirmed or suspected intestinal worm infections
• Adults with active or progressive vitiligo — particularly those not responding adequately to topical treatment alone
• Patients with recurrent aphthous stomatitis where frequency or severity warrants systemic treatment
• Children with frequently relapsing nephrotic syndrome under specialist paediatric supervision
• Individuals in high-risk communities or households where a family member has been diagnosed with a worm infection
• Patients in mass deworming programmes where a single-dose antiparasitic is indicated

Symptoms That May Indicate a Worm Infection:-

Worm infections can be asymptomatic for long periods. When symptoms do appear, common signs include:

• Stomach pain or cramping, particularly around the navel
• Bloating, gas, and abdominal distension
• Diarrhoea or alternating bowel habits
• Nausea and general malaise
• Unexplained weight loss despite normal or increased appetite
• Visible worms in the stool
• Intense anal itching, especially at night — hallmark of pinworm infection
• Fatigue and weakness
• Pale skin and signs of anaemia with heavy hookworm infection
• Disturbed sleep and irritability in children
• Cough or respiratory symptoms with migrating roundworm larvae

Common Side Effects:-

Dicaris Tablet is generally well-tolerated at standard doses. Commonly reported side effects include:

• Nausea — the most frequently reported, particularly on an empty stomach
• Vomiting
• Stomach pain or abdominal discomfort
• Diarrhoea
• Headache
• Dizziness
• Fatigue or general tiredness
• Altered taste sensation
• Mild skin rash or itching
• Temporary elevation of liver enzymes — usually insignificant at standard doses

Taking Dicaris with food and avoiding alcohol on dosing days helps reduce the most common side effects.

Serious Side Effects:-

Agranulocytosis. A severe reduction in white blood cells — particularly neutrophils — is the most serious known side effect of levamisole. It is rare at antiparasitic doses but more relevant with prolonged or higher-dose immunomodulatory use. Symptoms include sudden high fever, severe sore throat, mouth ulcers, and signs of serious infection. This is a medical emergency — seek immediate medical attention and stop the medicine.

Severe allergic reaction. Facial swelling, throat swelling, difficulty breathing, and widespread severe rash require immediate emergency medical help.

Liver toxicity. Jaundice, dark urine, persistent nausea, and right-sided abdominal pain may indicate liver problems. Report these promptly to your doctor.

Vasculitis. Purplish or bruise-like skin rash, joint pain, and swelling may indicate blood vessel inflammation with prolonged use. Inform your doctor if these develop.

Neurological effects. Dizziness, confusion, or unusual neurological symptoms should be reported to a doctor.

Disulfiram-like reaction with alcohol. Flushing, nausea, vomiting, and rapid heartbeat can occur if alcohol is consumed around the time of dosing.

Who Should Not Take Dicaris Tablet?

• Pregnant women — not recommended, particularly in the first trimester
• Breastfeeding women — consult a doctor before use
• People with a known allergy to levamisole or imidazothiazole compounds
• Patients with a history of agranulocytosis or significant blood disorders
• Those with severe liver disease
• Patients with epilepsy or seizure history — use with caution under medical supervision
• People taking warfarin or other anticoagulants — levamisole enhances anticoagulant effects

Drug Interactions:-

Warfarin and anticoagulants. Levamisole enhances the anticoagulant effect of warfarin, increasing bleeding risk. Close monitoring of clotting levels is essential if these medicines are used together.

Alcohol. Avoid alcohol on dosing days and 24 hours after — a disulfiram-like reaction can occur.

Phenytoin. Levamisole may increase phenytoin blood levels, raising the risk of toxicity. Inform your doctor if you take phenytoin.

Fluorouracil. Historically combined in oncology — relevant for patients in cancer treatment. Inform your oncologist of all medicines being taken.

Immunosuppressive medicines. Combined use requires careful medical supervision due to potentially unpredictable immune effects.

Piperazine-based antiparasitic medicines. Should not be combined with levamisole as their mechanisms oppose each other, reducing the effectiveness of both.

Monitoring During Long-Term Use:-

For patients taking Dicaris for immunomodulatory indications over extended periods:

• Full blood count before starting treatment and at regular intervals — typically every four to six weeks initially and every two to three months once stable
• Liver function tests periodically, particularly in patients with pre-existing liver conditions
• Report any fever, mouth ulcers, unusual tiredness, or signs of infection immediately and do not wait for a scheduled test
• Regular dermatology or specialist follow-up to assess treatment response and adjust the plan as needed

Storage Instructions:-

• Store Dicaris tablets at room temperature away from direct heat and sunlight
• Keep in the original packaging to protect from moisture
• Do not store in the bathroom or near a kitchen sink
• Keep out of reach of children and pets
• Check the expiry date before use and discard expired tablets
• Follow local guidelines for safe disposal of unused medicines

Frequently Asked Questions (FAQs)?

Q1. What is the Dicaris tablet used for?

Dicaris tablet is used primarily as an antiparasitic medicine to treat intestinal worm infections — particularly roundworm infections caused by Ascaris lumbricoides. It is also used for its immunomodulatory properties in conditions such as vitiligo, recurrent mouth ulcers, and paediatric nephrotic syndrome. The active ingredient levamisole works by causing spastic paralysis in worms and by modulating immune function in immune-related conditions.

Q2. How quickly does Dicaris Tablet work for worm infections?

Dicaris acts relatively quickly compared to many other antiparasitic medicines. Levamisole causes spastic paralysis in worms within hours of the dose being absorbed. Most patients notice worms being passed in their stool within a few hours to one day after taking the tablet. This rapid action is one of Dicaris’s practical advantages for treating roundworm infections.

Q3. Is one dose of Dicaris Tablet enough to treat a worm infection?

For most roundworm infections in adults, a single 150 mg dose of levamisole — equivalent to three Dicaris 50 mg tablets or one Dicaris 150 mg tablet — is sufficient. For pinworm infections, a repeat dose two to four weeks later is usually recommended to address newly hatched worms. Your doctor will advise on whether a single dose or a repeat treatment is appropriate for your specific infection.

Q4. Can Dicaris Tablet be used for children?

Yes. Dicaris is commonly used in children for intestinal worm infections, with the dose calculated based on the child’s body weight at approximately 2.5 mg per kilogram. It is also used in paediatric medicine for nephrotic syndrome under specialist supervision. Always have a doctor or paediatrician determine the correct dose and formulation for a child.

Q5. Why is Dicaris Tablet sometimes prescribed for vitiligo?

Vitiligo is believed to be driven by an autoimmune process in which the immune system attacks melanocytes — the cells that produce skin pigment. Levamisole has immunomodulatory properties that help restore regulatory T-cell function, reducing the autoimmune attack on melanocytes. Clinical studies have shown that levamisole — often used in an intermittent dosing schedule — can slow the progression of vitiligo and support repigmentation, particularly when combined with phototherapy.

Q6. Should I avoid alcohol while taking Dicaris Tablet?

Yes. Levamisole can cause a disulfiram-like reaction when combined with alcohol, resulting in flushing, nausea, vomiting, and an increased heart rate. It is strongly advisable to avoid alcohol on the day you take Dicaris and for at least 24 hours afterward. This applies regardless of whether you are taking it for antiparasitic or immunomodulatory purposes.

Disclaimer:-

The information provided in this article is for educational and informational purposes only. It is not intended to serve as a substitute for professional medical advice, diagnosis, or treatment. Always consult your doctor, pharmacist, or a qualified healthcare professional before starting, stopping, or making any changes to your medication or treatment plan.

Never ignore or delay seeking professional medical advice based on anything you have read in this article. Individual responses to medication can vary significantly, and only a licensed healthcare provider who is familiar with your complete medical history can determine whether this medication is appropriate for you.

This article does not promote or endorse the use of any specific medicine. All medication decisions should be made in consultation with a qualified medical professional.